Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Melanoma

Free Subscription Articles published in Melanoma Res Retrieve available abstracts of 150 articles: HTML format Text format

Single Articles

February 2012
1. ZERBINI G , Colucci A, Maestroni A, Miserocchi E, et al
   Increased stromal cell-derived factor-1 concentration levels in aqueous from patients with uveal melanoma.
   Melanoma Res. 2012;22:98-9.
   PubMed     Text format     Related articles   
   
   
   
   
2. KUZBICKI L , Lange D, Straczynska-Niemiec A, Chwirot BW, et al
   The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.
   Melanoma Res. 2012;22:70-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
3. LENTINI A , Tabolacci C, Nardi A, Mattioli P, et al
   Preclinical evaluation of the antineoplastic efficacy of 7-(2-hydroxyethyl)theophylline on melanoma cancer cells.
   Melanoma Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. BONAZZI VF , Stark MS, Hayward NK
   MicroRNA regulation of melanoma progression.
   Melanoma Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. LIU H , Wei Q, Gershenwald JE, Prieto VG, et al
   Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.
   Melanoma Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. BARR J , Amato CM, Robinson SE, Kounalakis N, et al
   The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma.
   Melanoma Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. VAARWATER J , van den Bosch T, Mensink HW, van Kempen C, et al
   Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
   Melanoma Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. TRAVES V , Botella-Estrada R, Requena C, Nagore E, et al
   Regression does not significantly underestimate melanoma thickness.
   Melanoma Res. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
9. NIKOLAOU VA , Sypsa V, Gogas H, Polydorou D, et al
   Evaluation of self-assessed melanoma growth rate in a Mediterranean patient population.
   Melanoma Res. 2011;21:560-2.
   PubMed     Text format     Related articles   
   
   
   
   
10. WEBER JS , Amin A, Minor D, Siegel J, et al
    Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial.
    Melanoma Res. 2011;21:530-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. HOFMANN MA , Hauschild A, Mohr P, Garbe C, et al
    Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice: a multicentre Dermatologic Cooperative Oncology Group trial.
    Melanoma Res. 2011;21:516-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
12. GREEN AC , Siskind V
    Risk factors for limb melanomas compared with trunk melanomas in Queensland.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. OLIVEIRA EA , Faintuch BL, Nunez EG, Maria Moro A, et al
    Radiotracers for different angiogenesis receptors in a melanoma model.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. GREENWALD HS , Friedman EB, Osman I
    Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. ITO T , Moroi Y, Oba J, Nakahara T, et al
    The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. GROTZ TE , Mansfield AS, Jakub JW, Markovic SN, et al
    Regional lymphatic immunity in melanoma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. HADDY N , Mousannif A, Paoletti C, Dondon MG, et al
    Radiotherapy as a risk factor for malignant melanoma after childhood skin hemangioma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
18. ORCURTO V , Denys A, Voelter V, Schalenbourg A, et al
    18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. ROBINSON DW JR , Cormier JN, Zhao N, Uhlar CM, et al
    Health-related quality of life among patients with metastatic melanoma: results from an international phase 2 multicenter study.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. JEN EY , Poindexter NJ, Farnsworth ES, Grimm EA, et al
    IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. HOOIJKAAS AI , Gadiot J, van Boven H, Blank C, et al
    Expression of the embryological morphogen Nodal in stage III/IV melanoma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. HOSSAIN D , Qian J, Adupe J, Drewnowska K, et al
    Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
    Melanoma Res. 2011;21:426-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. THILL M , Berna MJ, Grierson R, Reinhart I, et al
    Expression of CD133 and other putative stem cell markers in uveal melanoma.
    Melanoma Res. 2011;21:405-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. MOUAWAD R , Spano JP, Khayat D
    Are we entering a new era in melanoma treatment? Lesson from ASCO 2011.
    Melanoma Res. 2011;21:377-9.
    PubMed     Text format     Related articles   
    
    
    
    
25. OLBRYT M , Habryka A, Tyszkiewicz T, Rusin A, et al
    Melanoma-associated genes, MXI1, FN1, and NME1, are hypoxia responsive in murine and human melanoma cells.
    Melanoma Res. 2011;21:417-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. ABYSHEVA SN , Iyevleva AG, Efimova NV, Mokhina YB, et al
    KIT mutations in Russian patients with mucosal melanoma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
27. ANTONIADIS AG , Petridou ET, Antonopoulos CN, Dessypris N, et al
    Insulin resistance in relation to melanoma risk.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. JENSEN TO , Riber-Hansen R, Schmidt H, Jacques Hamilton-Dutoit S, et al
    Tumor and inflammation markers in melanoma using tissue microarrays: a validation study.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. RIDOLFI L , Petrini M, Fiammenghi L, Maria Granato A, et al
    Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. PAPASPYROU G , Garbe C, Schadendorf D, Werner JA, et al
    Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. HARLAN LC , Lynch CF, Ballard-Barbash R, Zeruto C, et al
    Trends in the treatment and survival for local and regional cutaneous melanoma in a US population-based study.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
32. WU ZS , Cheng XW, Wang XN, Song NJ, et al
    Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. KONSTANTINA A , Lazaris AC, Ioannidis E, Liossi A, et al
    Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ABBOTT RA , Acland KM, Harries M, O'Doherty M, et al
    The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. LO C , Lai TY, Yang JS, Yang JH, et al
    Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
    Melanoma Res. 2011;21:267-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. PATEL SP , Kim KB, Papadopoulos NE, Hwu WJ, et al
    A phase II study of gefitinib in patients with metastatic melanoma.
    Melanoma Res. 2011;21:357-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
37. KRUGER U , Kretschmer L, Thoms KM, Padeken M, et al
    Lymph node ultrasound during melanoma follow-up significantly improves metastasis detection compared with clinical examination alone: a study on 433 patients.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. VIHINEN PP , Ramadan S, Vuoristo MS, Hernberg M, et al
    Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. MERRILL RM
    Risk-adjusted melanoma skin cancer incidence rates in Whites (United States).
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
40. BLOCK MS , Suman VJ, Nevala WK, Kottschade LA, et al
    Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. KNOPF A , Plettenberg C, Pickhard A, Bas M, et al
    Analysis of the functional integrity of the p53 tumor-suppressor gene in malignant melanoma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. MASSARI NA , Medina VA, Martinel Lamas DJ, Cricco GP, et al
    Role of H4 receptor in histamine-mediated responses in human melanoma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. ORGAZ JL , Benguria A, Sanchez-Martinez C, Ladhani O, et al
    Changes in the gene expression profile of A375 human melanoma cells induced by overexpression of multifunctional pigment epithelium-derived factor.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. MOLHOEK KR , Shada AL, Smolkin M, Chowbina S, et al
    Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. DEBNIAK T , Jakubowska A, Serrano-Fernandez P, Kurzawski G, et al
    Association of MMP8 gene variation with an increased risk of malignant melanoma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. MERVIC L , Leiter U, Meier F, Eigentler T, et al
    Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients.
    Melanoma Res. 2011;21:244-52.
    PubMed     Text format     Related articles   
    
    
    
    
47. SIVRIDIS E , Koukourakis MI, Mendrinos SE, Karpouzis A, et al
    Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1.
    Melanoma Res. 2011;21:188-95.
    PubMed     Text format     Related articles   
    
    
    
    
48. CHI M , Dudek AZ
    Vaccine therapy for metastatic melanoma: systematic review and meta-analysis of clinical trials.
    Melanoma Res. 2011;21:165-74.
    PubMed     Text format     Related articles   
    
    
    
    
49. 
    Abstracts of the 7th European Association of Dermato-Oncology (EADO) Congress. June 20-23, 2011. Nantes, France.
    Melanoma Res. 2011;21 Suppl:e1-63.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
50. MITHANI SK , Smith IM, Califano JA
    Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. SELIM MA , Burchette JL, Bowers EV, de Ridder GG, et al
    Changes in oligosaccharide chains of autoantibodies to GRP78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survival.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. SUN D , Zhou M, Kowolik CM, Trisal V, et al
    Differential expression patterns of capping protein, protein phosphatase 1, and casein kinase 1 may serve as diagnostic markers for malignant melanoma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. BUZAID AC , Schmerling RA, Vieira Guedes RA, de Freitas D, et al
    High-dose interleukin-2 in patients with metastatic melanoma whose disease progressed after biochemotherapy.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. BOUWHUIS MG , Collette S, Suciu S, de Groot ER, et al
    Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-alpha (EORTC 18 952) and prognostic value on treatment outcome.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
55. GAVRIEL H , McArthur G, Sizeland A, Henderson M, et al
    Review: mucosal melanoma of the head and neck.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
56. KLINGENSTEIN A , Haritoglou I, Schaumberger MM, Nentwich MM, et al
    Receiver operating characteristic analysis: calculation for the marker 'melanoma inhibitory activity' in metastatic uveal melanoma patients.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
57. DEROSE ER , Pleet A, Wang W, Seery VJ, et al
    Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanoma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
58. KOSZTKA L , Rusznak Z, Nagy D, Nagy Z, et al
    Inhibition of TASK-3 (KCNK9) channel biosynthesis changes cell morphology and decreases both DNA content and mitochondrial function of melanoma cells maintained in cell culture.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
59. PFEIL AF , Leiter U, Buettner PG, Eigentler TK, et al
    Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. YI JH , Yi SY, Lee HR, Lee SI, et al
    Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. VARTANIAN A , Stepanova E, Grigorieva I, Solomko E, et al
    VEGFR1 and PKCalpha signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner.
    Melanoma Res. 2011;21:91-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. PONS F , Plana M, Caminal JM, Pera J, et al
    Metastatic uveal melanoma: is there a role for conventional chemotherapy? - A single center study based on 58 patients.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. GARCIA MS , Ono Y, Martinez SR, Chen SL, et al
    Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
64. GLUD M , Manfe V, Biskup E, Holst L, et al
    MicroRNA miR-125b induces senescence in human melanoma cells.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. BOECKMANN L , Nickel AC, Kuschal C, Schaefer A, et al
    Temozolomide chemoresistance heterogeneity in melanoma with different treatment regimens: DNA damage accumulation contribution.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. ABDEL-RAHMAN MH , Pilarski R, Massengill JB, Christopher BN, et al
    Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. BHATTACHARYA S , Darjatmoko SR, Polans AS
    Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
68. SHIMABUKURO F , Neto CF, Sanches JA, Gattas GJ, et al
    DNA damage and repair in leukocytes of melanoma patients exposed in vitro to cisplatin.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. VASCONCELLOS MC , Bezerra DP, Fonseca AM, Araujo AJ, et al
    The in-vitro and in-vivo inhibitory activity of biflorin in melanoma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. KOLANDJIAN NA , Patel SP, Papadopoulos NE, Bedikian AY, et al
    The left ventricle as the first site of uveal melanoma metastasis 13 years after treatment of the primary tumor.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. CHAILLOL I , Boniol M, Middleton R, Dore JF, et al
    Seasonality of cutaneous melanoma diagnosis in Northern Ireland with a review.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. WILGENHOF S , Pierret L, Corthals J, Van Nuffel AM, et al
    Restoration of tumor equilibrium after immunotherapy for advanced melanoma: three illustrative cases.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. FINK AM , Weihsengruber F, Duschek N, Schierl M, et al
    Value of micromorphometric criteria of sentinel lymph node metastases in predicting further nonsentinel lymph node metastases in patients with melanoma.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. HARIHARAN V , Toole T, Klarquist J, Mosenson J, et al
    Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment.
    Melanoma Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
75. MARTORELL-CALATAYUD A , Nagore E, Botella-Estrada R, Scherer D, et al
    Defining fast-growing melanomas: reappraisal of epidemiological, clinical, and histological features.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. ALVARADO GC , Papadopoulos NE, Hwu WJ, Bedikian AY, et al
    Pelvic computed tomography scans for surveillance in patients with primary melanoma in the head and neck.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. HE S , Li CG, Slobbe L, Glover A, et al
    PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. DE RIDDER GG , Gonzalez-Gronow M, Ray R, Pizzo SV, et al
    Autoantibodies against cell surface GRP78 promote tumor growth in a murine model of melanoma.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. MOUAWAD R , Spano JP, Khayat D
    Paving the way to the cure of melanoma.
    Melanoma Res. 2010;20:441-2.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
80. BEDIKIAN AY , Johnson MM, Warneke CL, Papadopoulos NE, et al
    Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. NAGY D , Kosztka L, Pap P, Nagy Z, et al
    Cytoplasmic Ca2+ concentration changes evoked by muscarinic cholinergic stimulation in primary and metastatic melanoma cell lines.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. IMHOF L , Goldinger SM, Baumann K, Schad K, et al
    The antibacterial substance, taurolidine in the second/third-line treatment of very advanced stage IV melanoma including brain metastases: results of a phase 2, open-label study.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
83. HAYASHI T , Chan M, Norton JT, Wu CC, et al
    Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. KLOSOWSKA-WARDEGA A , Hasumi Y, Ahgren A, Heldin CH, et al
    Combination therapy using imatinib and vatalanib improves the therapeutic efficiency of paclitaxel towards a mouse melanoma tumor.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. VALENZANO MENADA M , Moioli M, Garaventa A, Nozza P, et al
    Spontaneous regression of transplacental metastases from maternal melanoma in a newborn: case report and review of the literature.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. KONJEVIC G , Mirjacic Martinovic K, Vuletic A, Babovic N, et al
    In-vitro IL-2 or IFN-alpha-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. FALLER WJ , Rafferty M, Hegarty S, Gremel G, et al
    Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosis.
    Melanoma Res. 2010;20:392-400.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. HARBST K , Staaf J, Masback A, Olsson H, et al
    Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
    Melanoma Res. 2010;20:381-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
89. AGNARSDOTTIR M , Sooman L, Bolander A, Stromberg S, et al
    SOX10 expression in superficial spreading and nodular malignant melanomas.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. KLINGENSTEIN A , Haug AR, Nentwich MM, Tiling R, et al
    Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. HOMSI J , Bedikian AY, Papadopoulos NE, Kim KB, et al
    Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. HWU WJ , Knight RD, Patnana M, Bassett R, et al
    Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. DIVITO SJ , Ferris LK
    Advances and short comings in the early diagnosis of melanoma.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. MIKESH LM , Kumar M, Erdag G, Hogan KT, et al
    Evaluation of molecular markers of mesenchymal phenotype in melanoma.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. GLUD M , Rossing M, Hother C, Holst L, et al
    Downregulation of miR-125b in metastatic cutaneous malignant melanoma.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. FRANKENTHALER A , Sullivan RJ, Wang W, Renzi S, et al
    Impact of concomitant immunosuppression on the presentation and prognosis of patients with melanoma.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
97. MAKREDES M , Hui SK, Kimball AB
    Melanoma in Hong Kong between 1983 and 2002: a decreasing trend in incidence observed in a complex socio-political and economic setting.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. RICE ZP , Weiss FJ, Delong LK, Curiel-Lewandrowski C, et al
    Utilization and rationale for the implementation of total body (digital) photography as an adjunct screening measure for melanoma.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. VAN KILSDONK JW , Bergers M, Van Kempen LC, Schalkwijk J, et al
    Keratinocytes drive melanoma invasion in a reconstructed skin model.
    Melanoma Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. OHATA C , Yajima T, Yoneda M, Kikuchi M, et al
     MRI of severe regression of malignant melanoma.
     Melanoma Res. 2010;20:356-7.
     PubMed     Text format     Related articles   
     
     
     
     
101. GUITERA P , Bourgeat P, Stretch JR, Scolyer RA, et al
     Diagnostic value of 8.5 T magnetic resonance spectroscopy of benign and malignant skin lesion biopsies.
     Melanoma Res. 2010;20:311-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. VOIT CA , van Akkooi AJ, Schafer-Hesterberg G, Sterry W, et al
     The value of preoperative ultrasound (after lymphoscintigraphy) in conjunction with pre-sentinel lymph node biopsy fine-needle aspiration outweighs the usage of ultrasound alone in conjunction with lymphoscintigraphy: the need for an algorithm.
     Melanoma Res. 2010;20:357-9.
     PubMed     Text format     Related articles   
     
     
     
     
103. NIELSEN K , Harbst K, Masback A, Jonsson G, et al
     Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
     Melanoma Res. 2010;20:266-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
104. ROZENBERG GI , Monahan KB, Torrice C, Bear JE, et al
     Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. PANKA DJ , Sullivan RJ, Mier JW
     An inexpensive, specific and highly sensitive protocol to detect the BrafV600E mutation in melanoma tumor biopsies and blood.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. CROCETTI E , Caldarella A, Chiarugi A, Nardini P, et al
     The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. SZTRAMSKA A , Piwinski M, Chwirot BW
     Quantitative measurements of formalin-induced fluorescence for differential diagnostics of melanomas and lesions of human skin.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
108. AVILES-IZQUIERDO JA , Longo-Imedio MI, Lazaro-Ochaita P
     Acral cutaneous melanoma in a Spanish Caucasian population.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. HELMKE BM , Zahel T, Breinig M, Schirmacher P, et al
     Her2 overexpression is a rare event in anorectal melanoma.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. DE TORRE C , Garcia-Casado Z, Martinez-Escribano JA, Botella-Estrada R, et al
     Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. REICHE J , Pauli G, Ellerbrok H
     Differential expression of human endogenous retrovirus K transcripts in primary human melanocytes and melanoma cell lines after UV irradiation.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. KUNTE C , Geimer T, Baumert J, Konz B, et al
     Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. EICHHOFF OM , Zipser MC, Xu M, Weeraratna AT, et al
     The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. NEWTON-BISHOP J , Gruis N
     Melanoma susceptibility genes.
     Melanoma Res. 2010;20:161-2.
     PubMed     Text format     Related articles   
     
     
     
     
115. SAVOIA P , Fava P, Osella-Abate S, Nardo T, et al
     Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre.
     Melanoma Res. 2010;20:227-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. 
     Abstracts of the 6th Congress of the European Association of Dermatologic Oncology. June 16-19, 2010. Athens, Greece.
     Melanoma Res. 2010;20 Suppl:e1-91.
     PubMed     Text format     Related articles   
     
     
     
     May 2010
117. PINZANI P , Mazzini C, Salvianti F, Massi D, et al
     Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2010
118. DAVIS JL , Ripley RT, Frankel TL, Maric I, et al
     Paraneoplastic granulocytosis in metastatic melanoma.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. SCHINKE C , Mo Y, Yu Y, Amiri K, et al
     Aberrant DNA methylation in malignant melanoma.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. ZHANG S , Gao F, Wan D
     Abdominoperineal resection or local excision? a survival analysis of anorectal malignant melanoma with surgical management.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. TABOLACCI C , Lentini A, Provenzano B, Gismondi A, et al
     Similar antineoplastic effects of nimesulide, a selective COX-2 inhibitor, and prostaglandin E1 on B16-F10 murine melanoma cells.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. DAS P , Kumar N, Ahuja A, Jain A, et al
     Primary malignant melanoma at unusual sites: an institutional experience with review of literature.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. YOU Y , Ma L, You M, Li X, et al
     TSLC1 gene silencing in cutaneous melanoma.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. LASITHIOTAKIS KG , Petrakis IE, Garbe C
     Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. RUBEGNI P , Cevenini G, Sbano P, Burroni M, et al
     Evaluation of cutaneous melanoma thickness by digital dermoscopy analysis: a retrospective study.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. WILLIAMS MD , Esmaeli B, Soheili A, Simantov R, et al
     GPNMB expression in uveal melanoma: a potential for targeted therapy.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. DEBNIAK T , Gapska P, Serrano-Fernandez P, Rassoud I, et al
     Modest association of malignant melanoma with the rs910873 and rs1885120 markers on chromosome 20: a population-based study.
     Melanoma Res. 2010;20:159-60.
     PubMed     Text format     Related articles   
     
     
     
     
128. SOTO E , Lee H, Saladi RN, Gerson Y, et al
     Behavioral factors of patients before and after diagnosis with melanoma: a cohort study - are sun-protection measures being implemented?
     Melanoma Res. 2010;20:147-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. VIHINEN PP , Hernberg M, Vuoristo MS, Tyynela K, et al
     A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. SELVAN SR , Carbonell DJ, Fowler AW, Beatty AR, et al
     Establishment of stable cell lines for personalized melanoma cell vaccine.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. SVIATOHA V , Tani E, Kleina R, Sperga M, et al
     Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours.
     Melanoma Res. 2010;20:118-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
132. SAMIJA I , Lukac J, Maric-Brozic J, Buljan M, et al
     Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. BEDIKIAN AY , Richards J, Kharkevitch D, Atkins MB, et al
     A phase 2 study of high-dose allovectin-7 in patients with advanced metastatic melanoma.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. SCHUSTER R , Lindner M, Wacker F, Krossin M, et al
     Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. COOPER CL , Murali R, Doubrovsky A, Watson GF, et al
     Synchronous and metachronous malignancies in patients with melanoma: a clinicopathologic study highlighting the role of fine-needle biopsy cytology and potential diagnostic pitfalls.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. CHATTERJEE SJ , McNulty J, Pandey S
     Sensitization of human melanoma cells by tamoxifen to apoptosis induction by pancratistatin, a nongenotoxic natural compound.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. DENG WG , Kwon J, Ekmekcioglu S, Poindexter NJ, et al
     IL-24 gene transfer sensitizes melanoma cells to erlotinib through modulation of the Apaf-1 and Akt signaling pathways.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. TESTORI A , Rastrelli M, De Fiori E, Soteldo J, et al
     Radio-guided ultrasound lymph node localization: feasibility of a new technique for localizing and excising nonpalpable lymph nodes ultrasound suspicious for melanoma metastases.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. SCHARTZ NE , Farges C, Madelaine I, Bruzzoni H, et al
     Complete regression of a previously untreated melanoma brain metastasis with ipilimumab.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. LEITER U , Buettner PG, Eigentler TK, Forschner A, et al
     Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. BYERS HR , Boissel SJ, Tu C, Park HY, et al
     RNAi-mediated knockdown of protein kinase C-alpha inhibits cell migration in MM-RU human metastatic melanoma cell line.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. TODOROVIC V , Sersa G, Mlakar V, Glavac D, et al
     Metastatic potential of melanoma cells is not affected by electrochemotherapy.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2010
143. ABOURBIH DA , Di Cesare S, Orellana ME, Antecka E, et al
     Lysyl oxidase expression and inhibition in uveal melanoma.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. POPULO H , Soares P, Rocha AS, Silva P, et al
     Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. HU DN , Yu GP, McCormick SA
     Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2010
146. MOUAWAD R , Spano JP, Khayat D
     Old and new serological biomarkers in melanoma: where we are in 2009.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. BAIR WB 3RD , Cabello CM, Uchida K, Bause AS, et al
     GLO1 overexpression in human malignant melanoma.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. SOTELDO J , Ratto EL, Gandini S, Trifiro G, et al
     Pelvic sentinel lymph node biopsy in melanoma patients: is it worthwhile?
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. WIERZBICKA-HAINAUT E , Sassolas B, Mourey L, Guillot B, et al
     Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. TOPCU-YILMAZ P , Kiratli H, Saglam A, Soylemezoglu F, et al
     Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
     Melanoma Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: